Skip to main content
. 2016 Oct 25;21(6):961–970. doi: 10.1007/s10157-016-1340-2

Fig. 2.

Fig. 2

Remission and withdrawal rates of groups 1 and 2 at 12 and 24 months. Patients were divided according to MZR administration frequency—once-a-day (group 1) and 3-times-a-day (group 2)